3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neurofibromatosis 1
12
Neurofibroma, Plexiform
6
Carcinoma, Non-Small-Cell Lung
4
Neurofibrosarcoma
3
Neoplasms
3
Lung Neoplasms
3
Melanoma
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Muscle Invasive Bladder Cancer
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Astrocytoma
1
Advanced Non Small Cell Lung Cancer
1
Adenocarcinoma
1
Interventions
Rituximab
85
Cyclophosphamide
80
Prednisone
47
Doxorubicin
43
Lenalidomide
36
Vincristine
34
Magnetic Resonance Spectroscopy
29
polatuzumab vedotin
28
Gemcitabine
26
Etoposide
26
Specimen Handling
25
fludarabine
23
Biopsy
21
Oxaliplatin
20
CT-P10
20
glofitamab
16
tafasitamab
15
obinutuzumab
15
ibrutinib
13
fludarabine phosphate
13
zanubrutinib
12
axicabtagene ciloleucel
12
Immunotherapy, Adoptive
12
Ifosfamide
12
venetoclax
11
pembrolizumab
11
deltacortene
11
prednylidene
10
Prednisolone
10
Leukapheresis
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
AZD 6244
×
1 year
×
Clear all
No trials found.